Chengda biotechnology-Rabies vaccine-vaccines

中 / EN



中文 EN

Dedicated to evolving into a Preeminent International-level Biopharmaceutical Company

Integrity & Trustworthiness, Benevolence & Harmony, Responsibility & Collaboration

Dedicatedly offer top-tier biological products, wholeheartedly safeguarding the life and health of humanity





About Us

Dedicatedly Offer Top-tier Biological Products and Wholeheartedly Safeguarding the Life and Health of Humanity

Established in 2002, Liaoning Cheng Da Biotechnology Co., Ltd. has been on a remarkable journey with the corporate mission of Dedicatedly Offer Top-tier Biological Products and Wholeheartedly Safeguarding the Life and Health of Humanity, the core values of Integrity & Trustworthiness, Benevolence & Harmony, Responsibility & Collaboration, and the firmly corporate philosophy of Confronted Lives with Responsibility. CDBIO is striving to ascend to the ranks of outstanding international biopharmaceutical company.

Learn More

Over 2000 Districts & County-level CDCs

Marketing Coverage

Over 30 Countries

International Business

16.8 Billion Yuan

Operating Revenue in 2024

3 Manufacturing Bases

Manufacturing Facilities

2 R&D Centers

R&D Facilities

Over 20 Kinds of Vaccine Product

Products under Pipeline

Products

Market-launched Products 

Products in the Pipeline 

Inactivated Japanese Encephalitis Vaccine for Human Use (Vero cell) (IJEV)

SPEEDA-Rabies Vaccine for Human Use (Vero cell) (CPRV)

Beijing Cheng Da Tianhe Biotechnology Co., Ltd.

Beijing Cheng Da Tianhe Biotechnology Co., Ltd., a wholly-owned subsidiary of Liaoning Cheng Da Biotechnology Co., Ltd. (CDBIO) is a modern state-controlled biotechnology company dedicated to the research and development (R&D) of innovative vaccines within the realm of biopharmaceuticals, whose business scope encompasses the technology development, technology services, technology consultations, and technology transfer of innovative vaccines in the biopharmaceutical field.

Learn more 

Cheng Da Biotechnology (Benxi) Co., Ltd.

CDBIO (Benxi) is a wholly-owned subsidiary of Liaoning Cheng Da Biotechnology Co., Ltd. (CDBIO)

Learn more 

View Website 

Shenzhen Cheng Da Biotechnology Investment Co., Ltd.

Shenzhen Cheng Da Biotechnology Investment Co., Ltd. (CDBIO (Shenzhen)) is a wholly-owned subsidiary of Liaoning Cheng Da Biotechnology Co., Ltd. established in September 2023 with a registered capital of 200 million yuan. CDBIO (Shenzhen) is headquartered at the CVC Innovation Center for Listed Companies in Xiangmihu, Futian District, Shenzhen (the first CVC innovation service park for listed companies in China).

Learn more 